China plans to provide access to two imported antiretroviral drugs to address growing drug charge among some HIV-positive people in the country, Reuters Health reports. regimen with tenofovir, sold by Gilead chemistry under the brand name Viread, and Kaletra, a union of the protease inhibitors lopinavir and ritonavir and sold by Abbott Labs, can cost more than $1,500 annually.

More: - The rest...